Biased by design? Clinical trials and patient benefit in oncology

Future Oncol. 2020 Jan;16(3):4419-4423. doi: 10.2217/fon-2019-0763. Epub 2019 Dec 11.

Authors

Pan Pantziarka^{1

2}, Ciska Verbaanderd^{1

3}, Lydie Meheus¹

Affiliations

¹ The Anticancer Fund, 1853 Strombeek-Bever, Brussels, Belgium.
² The George Pantziarka TP53 Trust, London, UK.
³ Clinical Pharmacology & Pharmacotherapy, Department of Pharmaceutical & Pharmacological Sciences, KU Leuven, Belgium.

PMID: 31823651
DOI: 10.2217/fon-2019-0763

No abstract available

Keywords: clinical trial design; drug development; drug registration; patient benefit; risks of bias.

Publication types

Editorial
Comment

MeSH terms

Humans
Medical Oncology*
Research Design*